The 'Free Trial' That Costs You $12,500 a Year
ChurnKey's pricing page says "free until you recover revenue." Sounds fair, right? You only pay when it works.
Here's what they don't mention: when it works, you're paying 20-30% of every dollar recovered. Forever.
A founder on r/startups put it bluntly: "They take 30% on small recoveries; ate my margins... recovered $50k, still 25%—feels predatory."
Let's do the math on why "performance-based pricing" might be the most expensive trial you've ever run.
The Revenue Share Trap
Revenue share pricing feels psychologically safe. No upfront cost. No risk. You only pay when the tool "proves itself."
But here's the problem: the better the tool works, the more you pay.
Scenario: You're a B2B SaaS doing $50K MRR. Churn is 5% monthly. Failed payments add another 3%.
A good dunning tool recovers 40% of those failed payments. That's roughly $600/month recovered.
With ChurnKey at 25% revenue share: $150/month
Over a year: $1,800
Now scale that. At $100K MRR? $3,600/year. At $500K MRR? $18,000/year.
You're not paying for software. You're paying a permanent tax on your own revenue.
The 30-Day Hold Nobody Talks About
Here's the part that really stings: ChurnKey doesn't just take a cut—they hold your recovered funds for 30+ days before paying out.
So you're not just losing 25% of recovered revenue. You're also losing 30 days of cash flow on money your customers already paid.
For bootstrapped founders running lean? That's not a feature. That's a liquidity problem.
Why Founders Fall For It
I get the appeal. Performance-based pricing feels fair. You're not gambling $250/month on a tool that might not work.
But that's startup PTSD talking. We've all been burned by SaaS tools that overpromised and underdelivered. So we default to "I'll only pay if it works."
The problem: this mindset optimizes for the wrong thing.
You're not optimizing for "does this work?" You're optimizing for "does this feel safe in month one?"
What actually matters: total cost over 12 months. And by that metric, revenue share is almost always the most expensive option.
The Flat-Fee Alternative
Let's compare: Churn Buster charges $249/month flat. No revenue share.
Same $600/month recovery scenario:
- ChurnKey (25% share): $1,800/year
- Churn Buster (flat $249): $2,988/year
Wait—ChurnKey is cheaper at this scale?
Not for long.
At $100K MRR with $1,200/month recovered:
- ChurnKey: $3,600/year
- Churn Buster: $2,988/year
At $500K MRR with $6,000/month recovered:
- ChurnKey: $18,000/year
- Churn Buster: $2,988/year
The revenue share discount only exists when your tool doesn't work yet.
The moment it starts working—the moment you actually need it—you're paying 3x–6x more than flat pricing.
What I'd Do Differently
If I were building a churn recovery tool today (spoiler: I am—it's called Revive), here's what I'd fix:
Flat pricing, always. $49/month. No revenue share. Your recovered money goes to your bank account, not mine.
Instant payouts. Stripe pays you in 2 days. Your dunning tool shouldn't hold it for 30.
Transparent math. Show founders exactly what they'd pay with revenue share vs flat fee at their current MRR. Let them decide with real numbers.
Revenue share pricing isn't evil. It's just expensive. And most founders don't realize how expensive until they're locked in.
The Real Cost of 'Free'
Here's the uncomfortable truth: nothing is free.
When a SaaS tool says "free until you recover revenue," what they're really saying is: "We're betting you won't do the math on what this costs you long-term."
Performance-based pricing is a brilliant sales strategy. It removes objections. It feels risk-free.
But it's a terrible buying strategy if you plan to grow.
The best time to switch to flat pricing was before you signed up. The second-best time is now—before you've paid $18K for a $3K problem.
Tools mentioned:
- Revive: revive-hq.com (flat $49/month, no revenue share, supports Stripe + Lemon Squeezy + Paddle)
- ChurnKey: performance-based pricing (20-30% revenue share)
- Churn Buster: $249/month flat fee
Top comments (0)